Search Within

Martee L Hensley

  1. "Body Imaging Service"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (6)
Groups
  1. Body Imaging Service (13)
  2. Department of Medicine (13)
  3. GDMT, Medicine (13)
  4. Gynecologic Medicine Service (13)
  5. Gynecology Disease Management Team (13)
  6. Radiology, Department of (13)

More Groups

People
  1. Li-Xuan Qin (7)
  2. Mary Keohan (7)
  3. Robert Lefkowitz (6)
  4. Seth Cohen (6)
  5. Carol Aghajanian (5)
  6. Jason Konner (5)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (3)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. International Journal of Gynecological Cancer (2)
  3. Cancer (1)
  4. Clinical Cancer Research (1)
  5. Journal for ImmunoTherapy of Cancer (1)
  6. The Oncologist (1)
Publishers
  1. American Society of Clinical Oncology (7)
  2. Lippincott Williams & Wilkins (2)
  3. American Association for Cancer Research (1)
  4. Biomed Central Ltd (1)
  5. Oxford University Press (1)
  6. Wiley Blackwell (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
    Journal Article

    Movva, S.; Seier, K.; Bradic, M.; Charalambous, K.; Rosenbaum, E.; Kelly, C. M.; Cohen, S. M.; Hensley, M. L.; Avutu, V.; Banks, L. B.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Monitoring response to immune checkpoint inhibition in patients with endometrial cancer using cell-free DNA analysis
    Meeting Abstract

    Manning-Geist, B.; Patel, J.; Marra, A.; Zammarrelli, W. A. 3rd; Da Cruz Paula, A.; Abu-Rustum, N.; Shah, R.; Berger, M.; Hensley, M.; Lakhman, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Histology-specific clinical trial of lenvatinib and pembrolizumab in patients with sarcoma
    Journal Article

    Movva, S.; Seier, K.; Avutu, V.; Banks, L. B.; Chan, J.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Nacev, B. A.; Rosenbaum, E.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway
    Journal Article

    Rubinstein, M. M.; Hyman, D. M.; Caird, I.; Won, H.; Soldan, K.; Seier, K.; Iasonos, A.; Tew, W. P.; O’Cearbhaill, R. E.; Grisham, R. N.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • A phase II trial of sorafenib and dacarbazine for leiomyosarcoma, synovial sarcoma, and malignant peripheral nerve sheath tumors
    Journal Article

    D'Adamo, D. R.; Dickson, M. A.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C. M.; Ezeoke, M. O.; Ahn, L.; Qin, L. X.; Antonescu, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save